skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > pyrrolidines > n-acylpyrrolidine > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > pyrrolidines > n-acylpyrrolidine > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > pyrrolidines > n-acylpyrrolidine > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > pyrrolidines > n-acylpyrrolidine > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > pyrrolidines > n-acylpyrrolidine > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > pyrrolidines > n-acylpyrrolidine > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > pyrrolidines > n-acylpyrrolidine > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > n-acylpyrrolidine > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
organooxygen compound > oxacycle > oxadiazole > 1,2,4-oxadiazole > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > oxadiazole > 1,2,4-oxadiazole > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxadiazole > 1,2,4-oxadiazole > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxadiazole > 1,2,4-oxadiazole > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > oxadiazole > 1,2,4-oxadiazole > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxadiazole > 1,2,4-oxadiazole > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxadiazole > 1,2,4-oxadiazole > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxadiazole > 1,2,4-oxadiazole > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxadiazole > 1,2,4-oxadiazole > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxadiazole > 1,2,4-oxadiazole > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxadiazole > 1,2,4-oxadiazole > (2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine

Preferred term

(2s,3s)-3-/{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl/}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C17H22N4O4S

inchi

  • InChI=1S/C17H22N4O4S/c1-11(14(18)17(22)21-9-3-4-10-21)16-19-15(20-25-16)12-5-7-13(8-6-12)26(2,23)24/h5-8,11,14H,3-4,9-10,18H2,1-2H3/t11-,14-/m0/s1

inchikey

  • SQCDMTZMCHZYGO-FZMZJTMJSA-N

mass

  • 378.44714

monoisotopicmass

  • 378.13618

smiles

  • C[C@@H]([C@H](N)C(=O)N1CCCC1)c1nc(no1)-c1ccc(cc1)S(C)(=O)=O

subset

  • 3_STAR

synonym EXACT

  • (2S,3S)-3-{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine

synonym RELATED

  • (2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:39955

Download this concept:

RDF/XML TURTLE JSON-LD